Literature DB >> 26483414

NFAT2 Isoforms Differentially Regulate Gene Expression, Cell Death, and Transformation through Alternative N-Terminal Domains.

Pedro I Lucena1, Douglas V Faget1, Emilia Pachulec1, Marcela C Robaina2, Claudete E Klumb2, Bruno K Robbs3, João P B Viola3.   

Abstract

The NFAT (nuclear factor of activated T cells) family of transcription factors is composed of four calcium-responsive proteins (NFAT1 to -4). The NFAT2 (also called NFATc1) gene encodes the isoforms NFAT2α and NFAT2β that result mainly from alternative initiation exons that provide two different N-terminal transactivation domains. However, the specific roles of the NFAT2 isoforms in cell physiology remain unclear. Because previous studies have shown oncogenic potential for NFAT2, this study emphasized the role of the NFAT2 isoforms in cell transformation. Here, we show that a constitutively active form of NFAT2α (CA-NFAT2α) and CA-NFAT2β distinctly control death and transformation in NIH 3T3 cells. While CA-NFAT2α strongly induces cell transformation, CA-NFAT2β leads to reduced cell proliferation and intense cell death through the upregulation of tumor necrosis factor alpha (TNF-α). CA-NFAT2β also increases cell death and upregulates Fas ligand (FasL) and TNF-α in CD4(+) T cells. Furthermore, we demonstrate that differential roles of NFAT2 isoforms in NIH 3T3 cells depend on the N-terminal domain, where the NFAT2β-specific N-terminal acidic motif is necessary to induce cell death. Interestingly, the NFAT2α isoform is upregulated in Burkitt lymphomas, suggesting an isoform-specific involvement of NFAT2 in cancer development. Finally, our data suggest that alternative N-terminal domains of NFAT2 could provide differential mechanisms for the control of cellular functions.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26483414      PMCID: PMC4702591          DOI: 10.1128/MCB.00501-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway.

Authors:  Malte Buchholz; Alexandra Schatz; Martin Wagner; Patrick Michl; Thomas Linhart; Guido Adler; Thomas M Gress; Volker Ellenrieder
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

Review 2.  Transcription factors of the NFAT family: regulation and function.

Authors:  A Rao; C Luo; P G Hogan
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 3.  Structure and function of transcriptional activation domains.

Authors:  S J Triezenberg
Journal:  Curr Opin Genet Dev       Date:  1995-04       Impact factor: 5.578

Review 4.  NFAT transcription factors: from cell cycle to tumor development.

Authors:  J P B Viola; L D S Carvalho; B P F Fonseca; L K Teixeira
Journal:  Braz J Med Biol Res       Date:  2005-03-08       Impact factor: 2.590

5.  Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes.

Authors:  C Luo; E Burgeon; J A Carew; P G McCaffrey; T M Badalian; W S Lane; P G Hogan; A Rao
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

6.  IFN-gamma production by CD8+ T cells depends on NFAT1 transcription factor and regulates Th differentiation.

Authors:  Leonardo K Teixeira; Bruna P F Fonseca; Adriana Vieira-de-Abreu; Bianca A Barboza; Bruno K Robbs; Patrícia T Bozza; João P B Viola
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

7.  Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas.

Authors:  Lingchen Fu; Yen-Chiu Lin-Lee; Lan V Pham; Archito Tamayo; Linda Yoshimura; Richard J Ford
Journal:  Blood       Date:  2006-02-23       Impact factor: 22.113

8.  Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp.

Authors:  E Y Tsai; J Jain; P A Pesavento; A Rao; A E Goldfeld
Journal:  Mol Cell Biol       Date:  1996-02       Impact factor: 4.272

9.  Mechanisms of transactivation by nuclear factor of activated T cells-1.

Authors:  C Luo; E Burgeon; A Rao
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

10.  NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.

Authors:  Joseph R Arron; Monte M Winslow; Alberto Polleri; Ching-Pin Chang; Hai Wu; Xin Gao; Joel R Neilson; Lei Chen; Jeremy J Heit; Seung K Kim; Nobuyuki Yamasaki; Tsuyoshi Miyakawa; Uta Francke; Isabella A Graef; Gerald R Crabtree
Journal:  Nature       Date:  2006-03-22       Impact factor: 49.962

View more
  9 in total

1.  Pro-Apoptotic Antitumoral Effect of Novel Acridine-Core Naphthoquinone Compounds against Oral Squamous Cell Carcinoma.

Authors:  Bruna Costa Zorzanelli; Gabriel Ouverney; Fernanda P Pauli; Anna Carolina Carvalho da Fonseca; Elan Cardozo Paes de Almeida; Danielle Gonçalves de Carvalho; Patricia Abrão Possik; Vitor Won-Held Rabelo; Paula Alvarez Abreu; Bruno Pontes; Vitor Francisco Ferreira; Luana da Silva Magalhães Forezi; Fernando de Carvalho da Silva; Bruno Kaufmann Robbs
Journal:  Molecules       Date:  2022-08-12       Impact factor: 4.927

Review 2.  Cell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old player.

Authors:  G P Mognol; F R G Carneiro; B K Robbs; D V Faget; J P B Viola
Journal:  Cell Death Dis       Date:  2016-04-21       Impact factor: 8.469

3.  Priming of transcriptional memory responses via the chromatin accessibility landscape in T cells.

Authors:  Wen Juan Tu; Kristine Hardy; Christopher R Sutton; Robert McCuaig; Jasmine Li; Jenny Dunn; Abel Tan; Vedran Brezar; Melanie Morris; Gareth Denyer; Sau Kuen Lee; Stephen J Turner; Nabila Seddiki; Corey Smith; Rajiv Khanna; Sudha Rao
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

4.  NFAT1 and NFAT2 Differentially Regulate CTL Differentiation Upon Acute Viral Infection.

Authors:  Tianhao Xu; Ashleigh Keller; Gustavo J Martinez
Journal:  Front Immunol       Date:  2019-02-15       Impact factor: 7.561

5.  B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.

Authors:  James C Romero-Masters; Shane M Huebner; Makoto Ohashi; Jillian A Bristol; Bayleigh E Benner; Elizabeth A Barlow; Gail L Turk; Scott E Nelson; Dana C Baiu; Nicholas Van Sciver; Erik A Ranheim; Jenny Gumperz; Nathan M Sherer; Paul J Farrell; Eric C Johannsen; Shannon C Kenney
Journal:  PLoS Pathog       Date:  2020-02-14       Impact factor: 6.823

6.  NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway.

Authors:  Sanrong Xu; Penghao Shu; Song Zou; Xiaofeng Shen; Yuanqian Qu; Yong Zhang; Kang Sun; Jin Zhang
Journal:  Cancer Med       Date:  2018-08-07       Impact factor: 4.452

Review 7.  Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates.

Authors:  Silvia Belluti; Giovanna Rigillo; Carol Imbriano
Journal:  Cells       Date:  2020-03-20       Impact factor: 6.600

8.  NFAT2 overexpression suppresses the malignancy of hepatocellular carcinoma through inducing Egr2 expression.

Authors:  Jian Wang; Yamin Zhang; Lei Liu; Zilin Cui; Rui Shi; Jiancun Hou; Zirong Liu; Long Yang; Lianjiang Wang; Yang Li
Journal:  BMC Cancer       Date:  2020-10-06       Impact factor: 4.430

Review 9.  Isoform-Selective NFAT Inhibitor: Potential Usefulness and Development.

Authors:  Noriko Kitamura; Osamu Kaminuma
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.